Skip to main content

Table 5 Characteristics of each cost-effectiveness analysis (CEA) for pressure ulcers (n = 14)

From: A systematic review of cost-effectiveness analyses of complex wound interventions reveals optimal treatments for specific wound types

CEA (Original year of values)

Country (Original currency)

Perspective

Efficacy study design

Sample size

Population

Timeframe

Funding source a

Branom 2001 (2000) [64]

USA (US$)

Not reported

RCT

20

Mean 72 yrs; bedridden

max. 8 wks

Not reported

Burgos 2000 (1998) [65]

Spain (Pta)

Not reported

RCT

37

Mean 80 yrs

12 wks

Private

Chang 1998 (1997) [66]

Malaysia (RM)

Not reported

RCT

34

Mean 58 yrs

max. 8 wks

Private

Chuangsu-wanich 2011 (2010) [67]

Thailand (US$)

Not reported

RCT

45

Mean 66 yrs

8 wks

Not reported

Ferrell 1995 (1992) [68]

USA (US$)

Provider

RCT

84

Mean 81 yrs; mostly Caucasians; most fecal incontinence

52 wks

Mixed

Foglia 2012 (2010) [69]

Italy (€)

Provider

Observational

362

Most >80 yrs

4.3 wks

Not reported

Graumlich 2003 (2001) [70]

USA (US$)

Not reported

RCT

65

Mean 83 yrs

8 wks

Public

Muller 2001 (1998) [71]

The Netherlands (NLG)

Provider

RCT

24

Mean 73 yrs; all females

12 wks

Private

Narayanan 2005 (2004) [72]

USA (US$)

Not reported

Observational

976

Most ≥80 yrs; mostly Caucasians

approx. 22 wks

 

Payne 2009 (2007) [73]

USA (US$)

Provider

RCT

36

Mean 73 yrs

4 wks

Private

Robson 2000 (1999) [74]

USA (US$)

Not reported

RCT

61

Mean 50 yrs; mostly Caucasians

5 wks

Mixed

Sanada 2010 (2007) [75]

Japan (Yen)

Not reported

Observational

105

Mean 75 yrs

3 wks

Not reported

Xakellis 1992 (1990) [76]

USA (US$)

Not reported

RCT

39

Mean 80 yrs

1.4 wks

Mixed

Seberrn 1986 (1985) [77]

USA (US$)

Not reported

RCT

77

Mean 74 yrs

8 wks

Not reported

  1. RCT, Randomized clinical trial; SR, Systematic review; wks, Weeks; yrs, Years.
  2. aMixed here indicates both private and public funding.